Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Campylobacter jejuni Monoclonal Antibody

Product Overview

BioVenic mouse monoclonal antibody is specific for Campylobacter jejuni. It can be applied to ELISA and IF assays of Campylobacter jejuni.

Specifications

Application ELISA; IF

Clonality Monoclonal

Classification Primary Antibody

Clone L8N6

Host Mouse

Target Species Bacteria

Species Reactivity Bacteria

Specificity Campylobacter jejuni

Isotype IgM

Immunogen Native Campylobacter jejuni type 1

Purification Antigen Affinity Purified

Purity > 90%

Concentration 1 mg/mL

Conjugation Unconjugated

Preservative and Stabilizer 0.09% Sodium Azide

Buffer Phosphate Buffered Saline

Physical State Liquid

Target Information

Campylobacteriosis is a significant public health concern, causing a substantial number of gastroenteritis cases globally. Campylobacter typically colonizes the intestines of animals, especially poultry, cattle, and swine, without causing apparent disease in the animals. Human infection occurs through the ingestion of contaminated food or water. Clinical symptoms of Campylobacter infection in humans include diarrhea, abdominal cramps, fever, nausea, and vomiting.

Target Campylobacter jejuni

Target Synonym C. jejuni

Taxonomy ID 194

Shipping and Storage

This product is shipped with ice gel packs. Store at 4°C (up to 12 months) on receipt.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Tikhomirova, Alexandra, et al. "Campylobacter jejuni virulence factors: update on emerging issues and trends." Journal of Biomedical Science 31.1 (2024): 45.